-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Ngm Biopharmaceuticals Inc annual/quarterly Operating Lease, Payments history and growth rate from 2021 to 2023.
- Ngm Biopharmaceuticals Inc Operating Lease, Payments for the quarter ending March 31, 2023 was $1.3M, unchanged year-over-year.
- Ngm Biopharmaceuticals Inc annual Operating Lease, Payments for 2023 was $5.5M, a 3.77% increase from 2022.
- Ngm Biopharmaceuticals Inc annual Operating Lease, Payments for 2022 was $5.3M, a 3.92% increase from 2021.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)